Donanemab

From WikiMD.com - Food, Medicine & Wellness Encyclopedia

An article about Donanemab, a monoclonal antibody for Alzheimer's disease treatment


Donanemab[edit | edit source]

Amyloid plaque formation in Alzheimer's disease

Donanemab is a monoclonal antibody developed for the treatment of Alzheimer's disease. It targets a modified form of the beta-amyloid protein, which is implicated in the formation of amyloid plaques in the brains of individuals with Alzheimer's disease. These plaques are a hallmark of the disease and are believed to play a critical role in its pathogenesis.

Mechanism of Action[edit | edit source]

Donanemab works by binding to a specific form of beta-amyloid known as N3pG, which is a pyroglutamate-modified form of the protein. This binding facilitates the removal of amyloid plaques from the brain, potentially slowing the progression of Alzheimer's disease. The reduction of amyloid plaques is thought to improve cognitive function and slow the decline in patients with early symptomatic Alzheimer's disease.

Clinical Development[edit | edit source]

Donanemab has undergone several phases of clinical trials to assess its safety and efficacy. In early trials, it demonstrated the ability to reduce amyloid plaque levels in the brain, as measured by positron emission tomography (PET) imaging. Subsequent trials have focused on evaluating its impact on cognitive and functional outcomes in patients with Alzheimer's disease.

Potential Benefits[edit | edit source]

The primary benefit of donanemab is its potential to slow the progression of Alzheimer's disease by targeting and reducing amyloid plaques. This could lead to improved quality of life for patients and a delay in the progression of symptoms such as memory loss, confusion, and difficulty with daily activities.

Side Effects[edit | edit source]

As with many monoclonal antibodies, donanemab can cause side effects. Common side effects include infusion-related reactions, which may manifest as fever, chills, or rash. More serious side effects can include amyloid-related imaging abnormalities (ARIA), which are changes in the brain detected by MRI that can sometimes lead to symptoms such as headache, confusion, or nausea.

Future Directions[edit | edit source]

Research on donanemab continues, with ongoing studies aimed at better understanding its long-term effects and potential benefits in different stages of Alzheimer's disease. Researchers are also exploring combination therapies that might enhance the efficacy of donanemab or address other pathological features of Alzheimer's disease.

Related pages[edit | edit source]

WikiMD
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Transform your life with W8MD's budget GLP1 injections from $125

W8mdlogo.png
W8MD weight loss doctors team

W8MD offers a medical weight loss program NYC and a clinic to lose weight in Philadelphia. Our W8MD's physician supervised medical weight loss centers in NYC provides expert medical guidance, and offers telemedicine options for convenience.

Why choose W8MD?

Book Your Appointment

Start your NYC weight loss journey today at our NYC medical weight loss, and Philadelphia medical weight loss Call (718)946-5500 for NY and 215 676 2334 for PA

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's NYC physician weight loss.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available. Call 718 946 5500.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD